![]() Phathom Pharmaceuticals Phathom Pharmaceuticals is a biopharmaceutical company focused on treating gastrointestinal diseases and disorders. | ![]() Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | ![]() Juvenescence Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
| |
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 2016 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Buffalo Grove, US HQ Florham Park, US Menlo Park, US | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Dublin, IE HQ |
Employees | Employees 1633% increase | Employees 29723% increase | Employees 3310% increase |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 1.1 b | Valuation ($) 500 m |
Financial | |||
Revenue (est.) | Revenue (est.) $175.1m (FY, 2025) | Revenue (est.) €48.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $22.6m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $152.5m (FY, 2025) | Gross profit €53m (FY, 2025) | Gross profit N/A |
Net income | Net income ($221.2m) (FY, 2025) | Net income (€196.4m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 140m | Total funding raised $ 267.3m | Total funding raised $ 162.3m |

Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company
Juvenescence is a biotech longevity company that develops therapies and products targeting aging.
View company